Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CPS Innovations was a pioneering medical technology company specializing in the development and manufacture of Positron Emission Tomography (PET) and integrated PET/CT imaging systems. Established as a joint venture between CTI Molecular Imaging and Siemens Medical Solutions, the company was instrumental in advancing molecular imaging through the introduction of Lutetium Oxyorthosilicate (LSO) detector technology. Their systems allowed for the simultaneous capture of metabolic and anatomical data, revolutionizing diagnostic capabilities in oncology, cardiology, and neurology. Following Siemens' acquisition of CTI Molecular Imaging in 2005, CPS Innovations was fully integrated into the Siemens Healthineers portfolio, where its technology continues to underpin modern molecular imaging solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CPS Innovations.